---
title: "Oppenheimer Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286198191.md"
description: "Oppenheimer analyst maintained a Hold rating on Pliant Therapeutics yesterday. The company’s shares closed yesterday at $1.18.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks In addition to Oppenheimer, Pliant Therapeutics also received a Hold from Needham’s Joseph Stringer in a report issued yesterday. However, on the same day, Piper Sandler maintained a Buy rating on Pliant Therapeutics (NASDAQ: PLRX)."
datetime: "2026-05-13T04:55:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286198191.md)
  - [en](https://longbridge.com/en/news/286198191.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286198191.md)
generator: "portal-rs"
---

# Oppenheimer Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)

Oppenheimer analyst maintained a Hold rating on Pliant Therapeutics yesterday. The company’s shares closed yesterday at $1.18.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

In addition to Oppenheimer, Pliant Therapeutics also received a Hold from Needham’s Joseph Stringer in a report issued yesterday. However, on the same day, Piper Sandler maintained a Buy rating on Pliant Therapeutics (NASDAQ: PLRX).

### Related Stocks

- [PLRX.US](https://longbridge.com/en/quote/PLRX.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)

## Related News & Research

- [Grupa Azoty announces extraordinary shareholder meeting](https://longbridge.com/en/news/297635728.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)
- [Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News](https://longbridge.com/en/news/287275540.md)
- [Koala trial doses first patient with novel KMA‑targeting CAR‑T](https://longbridge.com/en/news/298021066.md)
- [Pliant Therapeutics (PLRX) Expected to Announce Quarterly Earnings on Monday](https://longbridge.com/en/news/285395454.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**